Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 3, 2000, Pages 1106-1111

  Ohsawa, M ^a   Mizoguchi, H ^a   Narita, M ^a   Chu, M ^a   Nagase, H ^a   Tseng, L F ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; DYNORPHIN A; ENDOMORPHIN 1; ENDOMORPHIN 2; METENKEPHALIN; METHYSERGIDE; NALTRIBEN; NORBINALTORPHIMINE; OPIATE PEPTIDE; SEROTONIN RECEPTOR; YOHIMBINE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; MALE; MOUSE; NONHUMAN; NORADRENERGIC SYSTEM; PAIN; PRIORITY JOURNAL; RECEPTOR BLOCKING; SEROTONINERGIC SYSTEM; SPINAL CORD;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BINDING, COMPETITIVE; IMMUNE SERA; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MICE; MICE, INBRED ICR; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; OPIOID PEPTIDES; PAIN; PAIN MEASUREMENT; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SEROTONIN ANTAGONISTS; SPINAL CORD;

EID: 0033847408     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Expression of two variants of the human μ opioid receptor mRNA in SK-N-SH cells and human brain
2. A method for determining loss of pain sensation
3. Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain
4. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse
5. Intrathecal morphine in mice: A new technique
6. Endomorphin-2 is an endogenous opioid in the primary sensory afferent fibers
7. Differential distribution of endomorphin-1 and endomorphin-2-like immunoreactivities in the CNS of the rodent
8. Localization of endomorphin-2-like immunoreactivity in the rat medulla and spinal cord
9. The μ-opioid receptor gene dose-dependent reductions in G-protein activation in the pons/medulla and antinociception induced by endomorphins in μ-opioid receptor knockout mice
10. 35S]GTPγS binding in the mouse spinal cord
11. Evidence for the existence of the beta-endorphin-sensitive 'ε-opioid receptor' in the brain: The mechanisms of ε-mediated antinociception
12. Identification and characterization of three new alternatively spliced μ-opioid receptor isoforms
13. Immunoreactivity for endomorphin-2 occurs in primary afferents in rats and monkey
14. An approach to the design of receptor-type selective nonpeptide antagonists of peptidergic receptors; δ opioid antagonists
15. 1-opioid receptor antagonists; 7-benzylididene naltrexamine
16. Immunofluorescent identification of endomorphin-2-containing nerve fibers and terminals in the rat brain and spinal cord
17. Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2
18. Intrathecal cholecystokinin octapeptide attenuates the antinociception and release of immunoreactive Met-enkephalin induced by intraventricular β-endorphin in the rat
19. Differential mechanisms mediating β-endorphin- and morphine-induced analgesia in mice
20. Stereoselective effect of β-endorphin on the production of analgesia and the spinal release of Met-enkephalin in rats
21. Mechanisms of β-endorphin-induced antinociception
22. Involvement of epsilon and kappa opioid receptors in inhibition of the tail-flick response induced by bremazocine in the mouse
23. Different mechanisms mediating tail-flick inhibition induced by β-endorphin, DAMGO and morphine form Rob and GiA in anesthetized rat
24. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse
25. 1 opioid receptors are involved in intracerebroventricular β-endorphin-induced antinociception in the mouse
26. Release of immunoreacitve Met-enkephalin from the spinal cord intraventricular β-endorphin but not morphine in anesthetized rats
27. 5]enkephalin and cholecystokinin from the spinal cord by β-endorphin administered intraventriculary in the pentobarbital-anesthetized rat
28. Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse
29. Differential descending pain control pathways involvement in mediating antinociception induced by supraspinally administered endogenous μ-opioid peptides endomorphin-1 and -2 in mouse
30. Differential mechanisms mediating antinociception induced by supraspinally administered newly discovered endogenous opioid peptides endomorphin-1 and -2 in the mouse
31. 5]-enkephalin antibody blocks analgesia induced by intracerebroventricular β-endorphin but not morphine in mice
32. Differential mechanisms mediate β-endorphin- and morphine-induced inhibition of the tail-flick response in rats
33. Spinal release of immunoreacitve Met-enkephalin by intraventricular β-endorphin and its analogs in anesthetized rats
34. Forebrain sites differentially sensitive to β-endorphin and morphine for analgesia and release of Met-enkephalin in the pentobarbital-anesthesized rat
35. Inhibition of spinal nitric oxide synthase by Nω-nitro-L-arginine blocks the release of Met-enkephalin and antinociception induced by supraspinally administered β-endorphin in the rat
36. Involvement of supraspinal ε and μ opioid receptors in inhibition of the tail-flick response induced by etorphine in the mouse
37. A potent and selective endogenous agonist for the μ-opioid receptor
38. Cloning and expression of an isoform of the rat μ opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1